Skye Bioscience

About:

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Top Investors: H. C. Wainwright & Co., 5AM Ventures, Ally Bridge Group, Driehaus Capital Management, Altium Capital

Description:

Skye Bioscience is a pharmaceutical company providing new therapeutic outcomes for diseases with significant prevalence and unmet needs. It develops proprietary molecules to treat diseases involving inflammatory, fibrotic, and metabolic conditions.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)skyebioscience.com

Founders:

Cosmas Lykos

Number of Employees:

11-50

Last Funding Date:

2024-01-29

IPO Status:

Public

Industries: